NCT07274813 2026-03-03A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid TumorsShanghai Henlius BiotechPhase EARLY_PHASE1 Recruiting254 enrolled